CIK 0001935979 · Large accelerated filer
Biohaven Ltd.
Sign in to watch- Ticker
- BHVN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Virgin Islands, British
- Entity type
- operating
- Phone
- 203-404-0410
- Business address
- 215 CHURCH STREET, NEW HAVEN, CT, 06510
- Former names
- Biohaven Research Ltd.
- 4 Open-market buy Chief Executive Officer bought 853,380 shares at $10.50 ($8,960,490)
- 4 Open-market buy Director bought 3,900,000 shares at $10.50 ($40,950,000)
- 4 Open-market buy Chief Financial Officer bought 142,857 shares at $10.50 ($1,499,999)
- 4 Open-market buy Director bought 9,523 shares at $10.50 ($99,992)
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1 Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- 4/A Other acquisition Chief Executive Officer acquired 0 shares (other)
- 4/A Shares withheld for taxes Director gave up 12,959 shares (to pay taxes)
- 4/A Shares withheld for taxes Director gave up 9,699 shares (to pay taxes)
- DRS Other Draft Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Open-market buy Chief Executive Officer bought 485,775 shares at an average $10.31 ($5,009,425)
- 4 Open-market buy Director bought 274,141 shares at an average $8.98 ($2,461,171)
- 4/A Other acquisition Chief Executive Officer acquired 461,470 shares (other)
Page 12 of 15 · 282 filings